These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18828626)

  • 61. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS; Black SR; Patel PR; So J; Mathews JM
    Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR; Hathaway LB
    Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions.
    Li G; Huang K; Nikolic D; van Breemen RB
    Drug Metab Dispos; 2015 Nov; 43(11):1670-8. PubMed ID: 26285764
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protein responses in blue mussels (Mytilus edulis) exposed to organic pollutants: a combined CYP-antibody/proteomic approach.
    Jonsson H; Schiedek D; Grøsvik BE; Goksøyr A
    Aquat Toxicol; 2006 Jun; 78 Suppl 1():S49-56. PubMed ID: 16603256
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes.
    Cho TM; Rose RL; Hodgson E
    Drug Metab Dispos; 2006 Jan; 34(1):176-83. PubMed ID: 16243959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved preparation and detection of cytochrome P450 isoforms using MS methods.
    Sutton CW; Sutherland M; Shnyder S; Patterson LH
    Proteomics; 2010 Jan; 10(2):327-31. PubMed ID: 19902426
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes.
    Lundblad MS; Stark K; Eliasson E; Oliw E; Rane A
    Biochem Biophys Res Commun; 2005 Feb; 327(4):1052-7. PubMed ID: 15652503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
    Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
    Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.
    Neve EP; Ingelman-Sundberg M
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):78-85. PubMed ID: 20047148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Methods of study on cytochrome P450 in relation to the metabolism and toxicity of alcohol and drugs].
    Nakajima T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Jun; 33(3):210-8. PubMed ID: 9701998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular modeling of human cytochrome P450-substrate interactions.
    Lewis DF
    Drug Metab Rev; 2002; 34(1-2):55-67. PubMed ID: 11996012
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans.
    Edwards RJ; Adams DA; Watts PS; Davies DS; Boobis AR
    Biochem Pharmacol; 1998 Aug; 56(3):377-87. PubMed ID: 9744576
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quantitative analysis of cytochrome p450 isozymes by means of unique isozyme-specific tryptic peptides: a proteomic approach.
    Alterman MA; Kornilayev B; Duzhak T; Yakovlev D
    Drug Metab Dispos; 2005 Sep; 33(9):1399-407. PubMed ID: 15951447
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolism of deltamethrin and cis- and trans-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes.
    Hedges L; Brown S; MacLeod AK; Vardy A; Doyle E; Song G; Moreau M; Yoon M; Osimitz TG; Lake BG
    Xenobiotica; 2019 May; 49(5):521-527. PubMed ID: 29779438
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
    Hakkola J; Pelkonen O; Pasanen M; Raunio H
    Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2008 Oct; 36(10):1983-91. PubMed ID: 18583509
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.
    Perloff ES; Mason AK; Dehal SS; Blanchard AP; Morgan L; Ho T; Dandeneau A; Crocker RM; Chandler CM; Boily N; Crespi CL; Stresser DM
    Xenobiotica; 2009 Feb; 39(2):99-112. PubMed ID: 19255936
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytochrome p450 and glutathione s-transferase mRNA expression in human fetal liver hematopoietic stem cells.
    Shao J; Stapleton PL; Lin YS; Gallagher EP
    Drug Metab Dispos; 2007 Jan; 35(1):168-75. PubMed ID: 17050647
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
    Kumar G; Lau H; Laskin O
    Cancer Chemother Pharmacol; 2009 May; 63(6):1171-5. PubMed ID: 19030860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.